Cargando…

COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.

Detalles Bibliográficos
Autores principales: Estirado, Alicia Domínguez, Ibarra, Gabriela Zambrano, Skrabski, Filip, De Castro Martínez, Francisco Javier, De Pedro, Julia, Sanz Sanz, Maria Pilar, Zubeldia, Jose, Rodriguez, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849526/
http://dx.doi.org/10.1016/j.jaci.2020.12.177
_version_ 1783645321740419072
author Estirado, Alicia Domínguez
Ibarra, Gabriela Zambrano
Skrabski, Filip
De Castro Martínez, Francisco Javier
De Pedro, Julia
Sanz Sanz, Maria Pilar
Zubeldia, Jose
Rodriguez, Elena
author_facet Estirado, Alicia Domínguez
Ibarra, Gabriela Zambrano
Skrabski, Filip
De Castro Martínez, Francisco Javier
De Pedro, Julia
Sanz Sanz, Maria Pilar
Zubeldia, Jose
Rodriguez, Elena
author_sort Estirado, Alicia Domínguez
collection PubMed
description
format Online
Article
Text
id pubmed-7849526
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78495262021-02-02 COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain. Estirado, Alicia Domínguez Ibarra, Gabriela Zambrano Skrabski, Filip De Castro Martínez, Francisco Javier De Pedro, Julia Sanz Sanz, Maria Pilar Zubeldia, Jose Rodriguez, Elena J Allergy Clin Immunol Article Published by Mosby, Inc. 2021-02 2021-02-01 /pmc/articles/PMC7849526/ http://dx.doi.org/10.1016/j.jaci.2020.12.177 Text en Copyright © 2020 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Estirado, Alicia Domínguez
Ibarra, Gabriela Zambrano
Skrabski, Filip
De Castro Martínez, Francisco Javier
De Pedro, Julia
Sanz Sanz, Maria Pilar
Zubeldia, Jose
Rodriguez, Elena
COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.
title COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.
title_full COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.
title_fullStr COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.
title_full_unstemmed COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.
title_short COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.
title_sort covid-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in madrid, spain.
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849526/
http://dx.doi.org/10.1016/j.jaci.2020.12.177
work_keys_str_mv AT estiradoaliciadominguez covid19severeasthmaandbiologicalstargetingtype2inflammationresultsinathirdlevelhospitalinmadridspain
AT ibarragabrielazambrano covid19severeasthmaandbiologicalstargetingtype2inflammationresultsinathirdlevelhospitalinmadridspain
AT skrabskifilip covid19severeasthmaandbiologicalstargetingtype2inflammationresultsinathirdlevelhospitalinmadridspain
AT decastromartinezfranciscojavier covid19severeasthmaandbiologicalstargetingtype2inflammationresultsinathirdlevelhospitalinmadridspain
AT depedrojulia covid19severeasthmaandbiologicalstargetingtype2inflammationresultsinathirdlevelhospitalinmadridspain
AT sanzsanzmariapilar covid19severeasthmaandbiologicalstargetingtype2inflammationresultsinathirdlevelhospitalinmadridspain
AT zubeldiajose covid19severeasthmaandbiologicalstargetingtype2inflammationresultsinathirdlevelhospitalinmadridspain
AT rodriguezelena covid19severeasthmaandbiologicalstargetingtype2inflammationresultsinathirdlevelhospitalinmadridspain